Involvement of the Gab2 scaffolding adapter in type I interferon signalling

被引:12
|
作者
Baychelier, Florence
Nardeux, Pierre-Claude
Cajean-Feroldi, Chantal
Ermonval, Myriam
Guymarho, Jacqueline
Tovey, Michaeel G.
Eid, Pierre
机构
[1] CNRS, FRE 2937, Lab Oncol Virale, F-94801 Villejuif, France
[2] CNRS, FRE 2937, Lab Differenciat Cellulaire & Prions, F-94801 Villejuif, France
关键词
interferon-receptor; gab2-mutagenesis; phosphorylation; proteomics;
D O I
10.1016/j.cellsig.2007.05.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferons (IFNs) are pleiotropic cytokines involved in the regulation of physiological and pathological processes. Upon interaction with their specific receptors, IFNs activate the Jak/STAT signalling pathway. Numerous studies suggest, however, that the classical Jak/STAT pathway cannot alone account for the wide range of IFN's biological effects. To better understand the role of alternative signalling pathways in the type I IFNs response, we analyzed novel tyrosine-phosphorylated proteins following IFN-alpha 2 stimulation. We showed for the first time that the Grb2-associated binder 2 (Gab2) protein is differentially phosphorylated upon the IFN subtype employed and the cells stimulated. We demonstrated that IFNAR1 physically interacts with Gab2. Moreover, the cellular content of Gab2 varies as a function of IFN receptor chain expression levels, and in particular of the ratio of IFNAR1 to IFNAR2, suggesting that Gab2 and IFNAR2 compete for interaction with IFNAR1. Analysis of Gab2 deletion mutants indicates that IFNAR1 might interact with a Gab2 region containing p85-P13'kinase binding sites. Our results shed new light on recent data involving both Gab2 and type I IFNs in osteoclastogenesis and oncogenesis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:2080 / 2087
页数:8
相关论文
共 50 条
  • [41] Type I Interferon Signalling and Ischemic Stroke: Mechanisms and Therapeutic Potentials
    Cui, Pan
    Song, Bo
    Xia, Zongping
    Xu, Yuming
    TRANSLATIONAL STROKE RESEARCH, 2024, 16 (3) : 962 - 974
  • [42] Decoding type I and III interferon signalling during viral infection
    Mesev, Emily, V
    LeDesma, Robert A.
    Ploss, Alexander
    NATURE MICROBIOLOGY, 2019, 4 (06) : 914 - 924
  • [43] Adipose type I interferon signalling protects against metabolic dysfunction
    Wieser, Verena
    Adolph, Timon Erik
    Grander, Christoph
    Grabherr, Felix
    Enrich, Barbara
    Moser, Patrizia
    Moschen, Alexander Rupert
    Kaser, Susanne
    Tilg, Herbert
    GUT, 2018, 67 (01) : 157 - 165
  • [44] Decoding type I and III interferon signalling during viral infection
    Emily V. Mesev
    Robert A. LeDesma
    Alexander Ploss
    Nature Microbiology, 2019, 4 : 914 - 924
  • [45] Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
    Duncan, Christopher J. A.
    Randall, Richard E.
    Hambleton, Sophie
    TRENDS IN GENETICS, 2021, 37 (01) : 46 - 58
  • [46] Role of the cytoplasmic domains of the type I interferon receptor subunits in signalling
    Prejean, C
    Colamonici, OR
    SEMINARS IN CANCER BIOLOGY, 2000, 10 (02) : 83 - 92
  • [47] Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension
    George, Peter M.
    Oliver, Eduardo
    Dorfmuller, Peter
    Dubois, Olivier D.
    Reed, Daniel M.
    Kirkby, Nicholas S.
    Mohamed, Nura A.
    Perros, Frederic
    Antigny, Fabrice
    Fadel, Elie
    Schreiber, Benjamin E.
    Holmes, Alan M.
    Southwood, Mark
    Hagan, Guy
    Wort, Stephen J.
    Bartlett, Nathan
    Morrell, Nicholas W.
    Coghlan, John G.
    Humbert, Marc
    Zhao, Lan
    Mitchell, Jane A.
    CIRCULATION RESEARCH, 2014, 114 (04) : 677 - 688
  • [48] The adapter molecule Gab2 is induced by lymphocyte activation and is involved in signaling by IL-2 and IL-15 but not other common γ chain-using cytokines.
    Gadina, M
    Sudarshan, C
    Visconti, R
    Gu, H
    Neel, BG
    O'Shea, JJ
    FASEB JOURNAL, 2000, 14 (06): : A1084 - A1084
  • [49] Targeting type I interferon (IFN) signalling in patients with RA with a high type I IFN gene signature
    Karonitsch, Thomas
    Yeghiazaryan, Lusine
    Lackner, Angelika
    Brezinsek, Hans Peter
    Stamm, Tanja A.
    Koenig, Franz
    Aletaha, Daniel
    Smolen, Josef S.
    RMD OPEN, 2022, 8 (02):
  • [50] Inhibition of type I interferon induction and signalling by mosquito-borne flaviviruses
    Cumberworth, Stephanie L.
    Clark, Jordan J.
    Kohl, Alain
    Donald, Claire L.
    CELLULAR MICROBIOLOGY, 2017, 19 (05)